NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
posted on
Nov 20, 2007 05:42AM
ALDA Pharmaceuticals Corp.NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERSTO: All holders of common shares of ALDA Pharmaceuticals Corp.We will hold the annual general meeting of our shareholders on Friday, December 14, 2007, atthe offices of Getz Prince Wells LLP, Suite 1810 – 1111 West Georgia Street, Vancouver, BritishColumbia. The meeting will start at 10:00 a.m. (Pacific time). We cordially invite you to attend andencourage you to do so.At the meeting we will:(1) present our financial statements for the year ended June 30, 2007 and the report of our auditor onthose statements;(2) appoint the auditor;(3) elect directors;(4) give annual approval, as required by the TSX Venture Exchange, to the Company’s existing 2003Stock Option Incentive Plan as more particularly described under the heading “Part 3 – TheBusiness of the Meeting – Annual Approval of Stock Option Plan”; and(5) consider any other proper business.An Information Circular prepared by management, together with a form of proxy, accompany this Noticeof Meeting and should be read in conjunction with this Notice of Meeting.November 13, 2007.By order of the Board of Directors“Terrance Owen”Terrance G. OwenCEO, President & DirectorIf you cannot attend, we encourage you to complete and return the enclosed form of proxyindicating your voting instructions. Please complete, date and sign your form of proxy and returnit by mail or fax to our transfer agent, Pacific Corporate Trust Company, 510 Burrard Street, 2ndFloor Vancouver, B.C. V6C 3B9 Canada; facsimile: (604) 689-8144. To be valid, a completed formof proxy must be received by our transfer agent by no later than 10:00 a.m. on Wednesday,December 12, 2007, or, if the meeting is adjourned, by no later than 48 hours (excluding Saturdays,Sundays and holidays) prior to the time of the adjourned meeting.If you are not a registered shareholder, please refer to the accompanying Information Circular forinformation on how to vote your shares.